CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

March 29, 2026 updated by: University of Hawaii
The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • Hawaii
      • Hilo, Hawaii, United States, 96720
        • Recruiting
        • Hilo Benioff Medical Center
        • Contact:
      • Honolulu, Hawaii, United States, 96813
      • Lihue, Hawaii, United States, 96766
        • Recruiting
        • Wilcox Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients must have been diagnosed with any cancer.
  • Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
  • Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.

Patients must be residents of Hawaii, Kauai, or Maui counties.

Exclusion Criteria:

  • Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient Education Intervention

A multimedia educational series is designed to provide patient education on cancer clinical trials.

The following topics are addressed:

  • What is a clinical trial?
  • Types of clinical trials.
  • Phases of clinical trials.
  • Benefits and drawbacks.
  • Costs.
  • FAQs. This section covers common myths and clarifies these myths using a Q&A format.
  • How to join a clinical trial. Information about eligibility and informed consent.
  • Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient.

The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation.
Other: Patient Education Intervention
Multimedia Educational Videos
Experimental: Provider Education Intervention

The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability.

Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes:

  • An overview of clinical trials infrastructure in Hawaii.
  • Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider.
  • An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions.
Other: Provider Education Intervention
Provider workshops via zoom

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patients' awareness and knowledge of clinical trials
Time Frame: 18 months
Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Hawaii

Collaborators

Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Izumi Okado, PhD, University of Hawaii Cancer Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 7, 2023

First Submitted That Met QC Criteria

January 30, 2024

First Posted (Actual)

February 2, 2024

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Okado-2023-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe